FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD...

22
FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California Irvine Orange, California

Transcript of FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD...

Page 1: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

FFR and Valvular Heart Disease

Morton J. Kern, MD

Chief of Medicine, VA Long Beach HCS Professor of Medicine

University California Irvine Orange, California

Page 2: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Disclosure: Morton J. Kern, MD Within the past 12 months, the presenter or their spouse/partner have had a financial interest/arrangement or affiliation with the organization listed below. Company Name Relationship St. Jude Medical Inc. Speakers’ Bureau Volcano Therapeutics Speakers’ Bureau Merit Medical Inc. Consultant Acist Medical Inc. Consultant Opsens Consultant

Page 3: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

FFR in Valvular Heart Disease Factors confounding interpretation of FFR Coronary Blood flow and Reserve Left Ventricular Hypertrophy and Strain Microvascular dysfunction Theoretical considerations for FFR in TAVR

Page 4: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Circulation 2003;107:3121-3123

CFR vs. LVH CFR vs. Diastolic Perfusion Time

Page 5: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Microvascular disease and CBF

LVH

Page 6: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

CVR vs Diastolic Perfusion Time

Circ 2002;105:470-476

Page 7: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Ventricular blood flow during hyperemia CVR

Page 8: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Period 1 = pre, period 2= 2-4h post, period 3= 1 day post

Page 9: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

JACC 2000

Page 10: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California
Page 11: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Systemic Vascular Load in Calcific Degenerative Aortic Valve

Stenosis: Insight From Percutaneous Valve Replacement

Yotti, et al. J Am Coll Cardiol. 2015;65(5):423-433.

Page 12: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Systemic Vascular Load in Calcific Degenerative Aortic Valve Stenosis: Insight From TAVR

Yotti, et al. J Am Coll Cardiol. 2015;65(5):423-433.

Page 13: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Davies J et al

Circulation, 2006

Wave reflections in the coronary circulation, Davies J et al 2006

Page 14: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

1 3 2

Wave Source

Aorta

Cor Artery

Wave reflections in the Coronary Circulation, Davies J et al, Circ. 2006

Page 15: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

4 5 6

Wave reflections in the Coronary Circulation, Davies J et al, Circ. 2006

Diastolic backward

suction wave

Page 16: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Arterial Pulse Wave Dynamics After Percutaneous Aortic

Valve Replacement Clinical Perspective

by Justin E. Davies, Sayan Sen, Chris Broyd, Nearchos Hadjiloizou, John Baksi,

Darrel P. Francis, Rodney A. Foale, Kim H. Parker, Alun D. Hughes, Andrew

Chukwuemeka, Roberto Casula, Iqbal S. Malik, Ghada W. Mikhail, and Jamil Mayet

Circulation Volume 124(14):1565-1572, October 4, 2011

Page 17: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Changes in coronary wave intensity analysis in a subject with severe

aortic stenosis before and after TAVR Justin E. Davies et al. Circulation. 2011;124:1565-1572

Page 18: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California
Page 19: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Improvement in physiological reserve in subjects with aortic stenosis

after percutaneous aortic valve replacement (PAVR).

Justin E. Davies et al. Circulation. 2011;124:1565-1572

Page 20: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

ACC 2015

Page 21: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Aortic

Stenosis Post TAVR

Aortic

Stenosis

TAVR

CFR

IMR

Dia Suction

Wave

LV Relax

FFR

Postulated Physiologic Changes after

TAVR for Lesion Assessment

Page 22: FFR and Valvular Heart Disease · 2017-07-13 · FFR and Valvular Heart Disease Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California

Coronary Blood flow in Aortic Valve Disease FFR and hypertrophy, microvascular dysfunction Coronary Artery Disease in Valvular Heart Disease Implications and Future considerations for FFR in Vavlular HD